10x genomics stock price.

NanoString Technologies Inc. -7.89%. $26.34M. TXG | Complete 10x Genomics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 10x Genomics offers a range of products for single-cell and spatial analysis, genome sequencing, and synthetic biology. Find the best product for your research needs with our product selector tool.10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on ...May 26, 2021 · The 10X Genomics stock forecast for tomorrow is $ 43.18, which would represent a -0.43% loss compared to the current price. In the next week, the price of TXG is expected to increase by 1.84% and hit $ 44.16. As far as the long-term 10X Genomics stock forecast is concerned, here’s what our ... The average price target represents a 24.95% change from the last price of $43.52. Price Target 10x Genomics Inc Stock forecast & analyst price target predictions based on 8 analysts offering 12-months price targets for TXG in the last 3 months.

10x Genomics, Inc. (TXG) Stock Price, Quote, News & Analysis Black Friday is here! Get Premium + Alpha Picks for ONLY $438 $239 » TXG 10x Genomics, …

10x Genomics Stock Forecast and Price Target. According to two esteemed experts, the average price target for 10x Genomics to reach this year is $60.00, with a potential upside of approximately 40.48%. This prediction is based on a high estimate of $70.00 and a low estimate of $30.00.PLEASANTON, Calif., July 13, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it will report financial results for the second quarter 2023 after market close on Thursday, August 3, 2023.

10x Genomics will host a conference call to discuss the first quarter 2022 financial results, business developments and outlook after market close on Wednesday, May 4, 2022 at 1:30 PM Pacific Time ...As of Dec. 31, 10x had $219.7 million in cash and cash equivalents, $210.2 million in marketable securities, and $2.6 million in restricted cash. 10x Genomics expects full-year 2023 revenue to be in the range of $580 million to $600 million, representing 12 percent to 16 percent growth over 2022 revenue.Nov 14, 2023 · Complete 10x Genomics Inc. stock information by Barron's. View real-time TXG stock price and news, along with industry-best analysis. 9/12/2023 10x Genomics shows rising price performance, earning an upgrade to... 10x Genomics Clears Technical Benchmark, Hitting 90-Plus RS Rating; Stocks Flashing Renewed Technical Strength: 10x ...Stock Price Forecast The 12 analysts offering 12-month price forecasts for 10X Genomics Inc have a median target of 60.00, with a high estimate of 70.00 and a low estimate of 30.00.

Since 10X Genomics Inc last announced earnings on 8/3/2023, its stock price has fallen 4.8% as of 8/8/2023. In comparison, the SPDR S&P; 500 ETF Trust (SPY) has risen 0.4% during that same time period. Important 10X Genomics Inc Earnings Metrics to Analyze. As of 8/8/2023, 10X Genomics Inc has a trailing 12-month earnings per share of $-1.69.

The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.

Oct 10, 2019 · 10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023 PR Newswire - Wed Oct 11, 3:05PM CDT. /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it will report financial results for the third... TXG : 38.51 (-1.13%) Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and investing.Shares of 10x Genomics are in a yearlong rut. After the company went public in 2019, its shares soared to a peak in mid-2021. Since then, however, TXG stock has generally trended down.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Nov 14, 2023 · Complete 10x Genomics Inc. stock information by Barron's. View real-time TXG stock price and news, along with industry-best analysis.

Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and investing.10x Genomics, Inc. (TXG *.BMV) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock 10x Genomics, Inc. | Mexican Stock Exchange: TXG ...Currently, 10X Genomics Inc does not have a price-earnings ratio. 10X Genomics Inc’s trailing 12-month revenue is $568.4 million with a -30.3% net profit margin. Year-over-year quarterly sales growth most recently was 28.1%. ... Overall, 10X Genomics Inc stock has a Value Score of 6, Estimate Revisions Score of 27 and Quality Score of 66.On Friday morning 10/27/2023 the 10x Genomics Inc Registered Shs -A- share started trading at the price of $37.61. Compared to the closing price on Thursday …Real time 10x Genomics (TXG) stock price quote, stock graph, news & analysis. View the latest 10x Genomics Inc. (TXG) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Stock split history for 10x Genomics since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.

10x Genomics (NASDAQ:TXG) adds US$133m to market cap in the past 7 days, though investors from a year ago are still down 75%. (Simply Wall St.) Dec-08-22 04:05PM. 10x Genomics Commercially Launches Xenium Platform for In Situ Analysis. (PR Newswire) +7.27%. Nov 29, 2023 · According to the issued ratings of 8 analysts in the last year, the consensus rating for 10x Genomics stock is Moderate Buy based on the current 1 hold rating and 7 buy ratings for TXG. The average twelve-month price prediction for 10x Genomics is $60.78 with a high price target of $75.00 and a low price target of $47.00. If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Nov 21, 2023 · Quotes. +8.40%. Delayed Quote Deutsche Boerse AG, November 21, 2023 at 09:41 am EST. More quotes. 10x Genomics, Inc. is a life science technology company. The Company's integrated platform solutions include instruments, consumables and software for analyzing biological systems. The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Investor Relations. We are a life science technology company building products to interrogate, understand and master biology. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. We have built deep expertise across diverse ...Don’t write all synthetic biology stocks off just because the meme stocks crashed and burned! Here are 3 DNA stocks to buy for the synthetic biology revolution. TXG 10x Genomics $52.64 CRL ...

Quotes. +8.40%. Delayed Quote Deutsche Boerse AG, November 21, 2023 at 09:41 am EST. More quotes. 10x Genomics, Inc. is a life science technology …

Sep 8, 2023 · With a market cap of $5.60 billion and a stock price of $47.36 per share, it's worth comparing these figures to the estimated fair value of the stock, also known as the GF Value.

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC") has declined to issue a second preliminary injunction ...10x Genomics (TXG) delivered earnings and revenue surprises of -15.79% and 4.22%, respectively, for the quarter ended March 2023. ... The sustainability of the stock's immediate price movement ...Price T Rowe Associates Inc md/. 2.78%. 2,657,324. $115,647. Invesco. 2.33%. 2,226,466. $96,896. 10x Genomics, Inc., a life science technology company, …2,078.70 +21.50(+1.05%) Advertisement 10x Genomics, Inc. (TXG) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 45.22 +1.70 (+3.92%) As of 12:11PM EST. Market open. 1d 5dBased on our forecasts, a long-term increase is expected, the "TXG" stock price prognosis for 2028-11-24 is 88.040 USD. With a 5-year investment, the revenue is ...Jan 7, 2022 · If you are thinking of buying or selling 10x Genomics stock, ... The 52-week range of Verizon's stock price was $30.135 to $44.73. Verizon's dividend yield is 7.24%. It paid $8.2 billion in ... Nov 29, 2023 · A high-level overview of 10x Genomics, Inc. (TXG) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 10x Genomics (TXG) delivered earnings and revenue surprises of -15.79% and 4.22%, respectively, for the quarter ended March 2023. ... The sustainability of the stock's immediate price movement ...All information about 10x Genomics, Inc. (TXG) - stock price, quote chart, key statistics, dividends, company news and more.TXG 10x Genomics Inc - Class A Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NASDAQ)

Future criteria checks 4/6. 10x Genomics is forecast to grow earnings and revenue by 57.1% and 14% per annum respectively. EPS is expected to grow by 57.5% per annum. Return on equity is forecast to be -13.2% in 3 years.10x Genomics Cloud Analysis enables you to process your single cell gene expression data through a simple web interface, leveraging an optimized, scalable infrastructure for fast results. Users can set up and run Cell Ranger pipelines through Cloud Analysis. Cell Ranger is a set of analysis pipelines that will automatically generate expression profiles for each …1) 10x Genomics, Inc. TXG. Description: 10x Genomics is a biotechnology company focused on developing advanced genomic tools and technologies to enable researchers to gain deeper insights into ...Instagram:https://instagram. free alternative to turbotaxgold bars costnorway wealth fundhealth insurance companies in new jersey Best genomics stocks of 2023. Data source: The Motley Fool. Data current as of June 14, 2023. Genomics Company. Market Capitalization. Description. Illumina ( NASDAQ:ILMN ) $32.4 billion. Industry ... how to invest in paintingsirt stock 10x Genomics, Inc. Class A Common Stock (TXG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.10x Genomics Stock Forecast and Price Target. According to two esteemed experts, the average price target for 10x Genomics to reach this year is $60.00, with a potential upside of approximately 40.48%. This prediction is based on a high estimate of $70.00 and a low estimate of $30.00. where to buy over the counter stocks Jul 11, 2023 · At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. What is the target price for 10x Genomics (TXG) stock? The latest price target for 10x Genomics ( NASDAQ: TXG) was reported by Barclays on Friday, September 29, 2023. The analyst firm set a price ...10x Genomics : Provides high ... Sells DNA at rock bottom prices, a necessary ingredient for the synthetic biology revolution. ... 10x Genomics stock fell hard during the biotech crash of 2022 ...